Mayne Pharma Group Limited (ASX:MYX) Announces 1H FY25 Market Update
Mayne Pharma (ASX:MYX) expects 12-14% revenue growth and a 275-300% EBITDA increase for 1H FY25, driven by key sectors.

Mayne Pharma (ASX:MYX) expects 12-14% revenue growth and a 275-300% EBITDA increase for 1H FY25, driven by key sectors.
WAM Global Limited (ASX:WGB) declares increased fully franked interim and special dividends following strong investment portfolio performance.
JB Hi-Fi Limited (ASX:JBH) reports HY25 results with 9.8% sales growth, increased earnings, and a higher interim dividend.
Janison Education Group Limited (ASX:JAN) releases 1H25 results with 3% revenue growth and a 280% increase in customer pipeline.
Ansell Limited (ASX:ANN) reports a 29.9% revenue increase for H1 and announces an interim dividend of 22.20 US cents per share.
PM Capital Global Opportunities Fund Limited (ASX:PGF) announces a 3% revenue growth and 11% profit increase for the half-year ended December 2024.
Sigma Healthcare (ASX:SIG) upgrades its FY25 EBIT guidance to $64-$70 million, driven by improved operational performance and strong contract execution.
DigitalX Limited (ASX:DCC) updates January 2025 treasury holdings and fund performance, highlighting increased Solana holdings and strong returns.
Pact Group Holdings Ltd (ASX:PGH) responds to ASX price query, outlining financial performance and upcoming half-year earnings release.
Spacetalk Ltd (ASX:SPA) receives a $428,853 R&D tax rebate, highlighting strong financial discipline and continued investment in product development.